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Abstract
Background: Genetic studies have shown that formation of pancreatic endocrine cells in mice is
dependent on the cell autonomous action of the bHLH transcription factor Neurogenin3 and that
the extent and timing of endocrine differentiation is controlled by Notch signaling. To further
understand the mechanism by which Notch exerts this function, we have investigated pancreatic
endocrine development in chicken embryos.
Results: In situ hybridization showed that expression of Notch signaling components and pro-
endocrine bHLH factors is conserved to a large degree between chicken and mouse. Cell
autonomous inhibition of Notch signal reception results in significantly increased endocrine
differentiation demonstrating that these early progenitors are prevented from differentiating by
ongoing Notch signaling. Conversely, activated Notch1 induces Hes5-1 expression and prevents
endocrine development. Notably, activated Notch also prevents Ngn3-mediated induction of a
number of downstream targets including NeuroD, Hes6-1, and MyT1 suggesting that Notch may act
to inhibit both Ngn3 gene expression and protein function. Activated Notch1 could also block
endocrine development and gene expression induced by NeuroD. Nevertheless, Ngn3- and
NeuroD-induced delamination of endodermal cells was insensitive to activated Notch under these
conditions. Finally, we show that Myt1 can partially overcome the repressive effect of activated
Notch on endocrine gene expression.
Conclusion: We conclude that pancreatic endocrine development in the chicken relies on a
conserved bHLH cascade under inhibitory control of Notch signaling. This lays the ground for
further studies that take advantage of the ease at which chicken embryos can be manipulated.
Our results also demonstrate that Notch can repress Ngn3 and NeuroD protein function and
stimulate progenitor proliferation. To determine whether Notch in fact does act in Ngn3-
expressing cells in vivo will require further studies relying on conditional mutagenesis.
Lastly, our results demonstrate that expression of differentiation markers can be uncoupled from 
the process of delamination of differentiating cells from the epithelium.
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Background
The pancreas is an organ containing both exocrine and
endocrine cell populations. The exocrine pancreas con-
sists of acini and ducts that produce and transport
enzymes and bicarbonate to the digestive tract. Lineage
tracing studies have revealed that both endocrine and exo-
crine cells are derived from Pdx1-expressing progenitors
[1-3]. The endocrine cells are organized in the islets of
Langerhans which contain five distinct cell types, each
characterized by the production of specific peptide hor-
mones [4-6]. Endocrine cells begin to appear soon after
the first morphological signs of pancreas formation which
occurs approximately at the 25-somite stage in the mouse
and chicken [7]. Endocrine development depends on
Neurogenin3 (Ngn3) and is initiated by the onset of Ngn3
expression in a subset of pancreatic progenitor cells [8-
11]. All endocrine cells are derived from Ngn3 expressing
precursors and the vast majority, if not all, of the Ngn3
expressing cells are committed to the endocrine lineage
[1,12]
Several studies have demonstrated that Notch signaling is
involved in the development of endocrine cells in the
pancreas. Mice harboring mutations in the Notch path-
way genes Dll1, RBK-Jκ, and Hes1 all display precocious
and excessive endocrine development as early as E9.5
[10,13]. At this stage there is an increase in the numbers
of Ngn3 positive cells in Dll1 and RBP-Jκ mutants, and at
E10.5 an increase in endocrine cells. Ngn3 expression was
not analyzed in Hes1  mutants but these had increased
numbers of glucagon-producing cells at E9.5. Together
these studies suggest that Notch signaling prevents endo-
crine differentiation through a mechanism known as lat-
eral inhibition where the Notch ligand Dll1, expressed in
differentiating cells, signals through Notch receptors on
adjacent cells thereby keeping them undifferentiated or
acquiring a secondary fate. However, Notch signaling may
act to regulate differentiation by controlling the proneural
genes at the transcriptional level or Notch signaling could
act in already committed precursors by inhibiting prone-
ural factors posttranslationally. These are not mutually
exclusive mechanisms and indeed both have been pro-
posed [14-16]. Later studies have suggested that Notch
signaling not only regulates endocrine specification but
also inhibits exocrine differentiation [17,18]. This was
further supported by the finding that Hes1, a Notch target
gene, is active in exocrine precursors in the mouse pan-
creas and prevents their terminal differentiation, and that
loss of Notch signaling in zebrafish accelerate exocrine
differentiation [19]. Subsequently, Jagged mediated
Notch signaling has been suggested to mediate a fate
choice between exocrine and intrapancreatic duct fate
from a common precursor cell in zebrafish [20]. This is
most likely different from the situation in mice where
duct cell progenitors and exocrine progenitors appear to
diverge very early in development between E9.5 and
E11.5, prior to expression of Jagged-1 [1,21].
Here we show that the expression of pro-endocrine bHLH
factors and Notch pathway components is conserved in
the embryonic chicken pancreas and identify Hes6-1 as
being expressed in the endocrine lineage in the embryonic
pancreas. We demonstrate that inhibition of Notch sign-
aling results in increased endocrine differentiation, and
that activated Notch1 (Notch1ICD) blocks endocrine
development and maintains proliferation of pancreatic
progenitor cells in the embryonic chicken pancreas. We
demonstrate that Notch1ICD is able to inhibit Ngn3 activ-
ity as it prevents Ngn3 induced endocrine differentiation,
visualized by loss of NeuroD, Myt1, Hes6-1, Pax6, βIII-
tubulin, and glucagon expression but, remarkably, with-
out affecting delamination of the Ngn3-expressing cells
from the gut epithelium. We also show that NeuroD-
induced endocrine development is sensitive to inhibition
by Notch. Lastly, we show that forced expression of Myt1
partly restores βIII-tubulin expression in Notch1ICD
expressing cells. Together, our results demonstrate that
Notch regulation of pancreatic endocrine development is
conserved in chicken, and raises a possibility of Notch
mediated inhibition of Ngn3 and NeuroD protein activ-
ity.
Results
The embryonic chicken pancreas expresses pro-endocrine 
bHLH genes
Pancreatic endocrine development in the mouse relies on
the pro-endocrine genes Ngn3  and NeuroD  [1,8-10,22]
whose activity is, at least partly, controlled by Hes1 and
Notch signaling [10,13,17,18]. To determine if these
genes are expressed in the chicken pancreas we performed
in situ hybridizations on sections of HH st. 22 [23] (E4)
and HH st. 31 (E7) chicken pancreas (Fig. 1). These time-
points correspond roughly to E11 and E14 of mouse pan-
creas development where the epithelium expands and the
endocrine and exocrine differentiation peaks, respec-
tively. At HH st. 22, Ngn3 was expressed in a few scattered
cells within the epithelium (Fig. 1A) while NeuroD was
expressed in clusters of endocrine cells located at the distal
part of the dorsal pancreatic bud (Fig. 1B) as determined
by co-staining for Nkx6.1, a marker of pancreatic progen-
itor cells as well as β-cells, and glucagon expressed by the
α-cells (not shown). The chicken Hes1 homologue, for-
merly known as Hairy1  [24], now Hes1  after official
nomenclature, was expressed broadly in the pancreatic
epithelium at HH st. 22 (Fig. 1C) while Hes6-1  was
expressed in scattered cells within the epithelium (Fig.
1D). In the HH st. 31 pancreas, the overall expression pat-
terns were similar to the HH st. 22 pancreas (Fig. 1E–L),
but we consistently observed that Hes1 expression levels
varied between different regions of the epithelium suchBMC Developmental Biology 2007, 7:63 http://www.biomedcentral.com/1471-213X/7/63
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that areas with low levels of Hes1  expression corre-
sponded to regions where Ngn3  and  Hes6-1  were
expressed (Fig. 1E,G,H). To further define the cell types
that expressed the four bHLH genes we used immunohis-
tochemical detection of glucagon, amylase, and Nkx6.1
on sections previously subjected to in situ hybridization.
We found that regions expressing high levels of Hes1
(boxed area in fig. 1G) were devoid of glucagon (data not
shown), whereas amylase was readily detectable in Hes1-
expressing cells (Fig. 1K). Ngn3  and Hes6-1  were both
expressed in pancreatic progenitor cells marked by Nkx6.1
[25,26], but absent from glucagon-producing cells (Fig. 1I
and 1L). NeuroD expression was restricted to clusters of
endocrine cells (including Nkx6.1+  insulin-producing
cells) adjacent to the Nkx6.1 positive epithelium (Fig.
1F,J). We also analyzed the expression of Hes6-2 and
Hes5-1, -2, and -3 [27], but could not detect any tran-
scripts in the pancreas. Lastly, using whole-mount in situ
hybridization on micro-dissected HH st. 22 chicken pan-
creas we observed expression of Delta1, Notch1, and the
chicken Jagged-1 and -2 homologs Serrate-1 and -2 (data
not shown), but due to technical limitations we were not
able to further define the cell types that expressed these
genes.
Forced expression of Notch ligands induces endocrine 
differentiation
Expression of pro-endocrine and Notch pathway genes
suggests that Notch signaling might regulate endocrine
development in the chicken pancreas. If the function of
Delta1 is to signal to adjacent progenitor cells and prevent
them from entering the endocrine differentiation pro-
gram, then forced widespread expression of Delta1 in the
pancreatic epithelium should reduce the number of endo-
crine cells formed. To test this prediction, we introduced
plasmids expressing Delta1 upstream of an IRES-GFP cas-
sette into the endoderm of HH st. 10–12 and HH st. 13–
15 embryos by in ovo endoderm electroporation [11] and
assayed pancreatic endocrine differentiation after 72
hours (at HH st. 26–27) by staining for GFP, insulin, and
glucagon (Fig. 2). Embryos electroporated with an IRES-
GFP vector lacking the insert served as controls. We found
that extensive expression of Delta1 in both HH st. 10–12
and HH st. 13–15 embryos resulted in a marked increase
in the fraction of GFP-expressing cells that differentiate
into endocrine cells, compared to controls (Fig. 2A,B and
2E). At a first glance this result may seem paradoxical, but
we speculate that a cell autonomous dominant negative
action of high levels of Delta1 on Notch signaling [28-33]
results in increased endocrine differentiation. Support for
such a cell autonomous dominant negative effect comes
from additional experiments where we introduced either
Serrate1, or a C-terminally truncated form of Serrate1,
(Serrate1-d1), lacking signaling activity and previously
shown to act in a cell autonomous dominant negative
fashion [28]. Such embryos showed an increase in endo-
crine differentiation that was comparable to that seen
with Delta1 regardless of whether full-length or truncated
Serrate1 was used (Fig. 2, compare C, D to A, B), arguing
that the differentiation inducing effects seen when over-
expressing full-length Delta1 and Serrate1 is the result of
a cell autonomous inhibition of Notch signal reception.
Expression of bHLH genes in the chicken pancreas Figure 1
Expression of bHLH genes in the chicken pancreas. 
(A-L) In situ hybridization on serial sections from HH st. 22 
(A-D) and HH st. 31 (E-L) chick pancreas showing the 
expression patterns of Ngn3 (A, E, I), NeuroD (B, F; J), Hes1 
(C, G, K), Hes6-1 (D, H, L). Dorsal (dp) and ventral pancreas 
(vp) and the bile duct (bd) are indicated in A-D. At HH st. 22, 
Ngn3 is expressed in a few cells scattered in the epithelium 
(A) whereas NeuroD expression is confined to endocrine cell 
clusters located at the most distal part of the dorsal pancreas 
(red dashed lines in B). Hes1 is expressed broadly in the dp 
and vp epithelium as well as in the bd epithelium (C). Hes6-1 
is expressed in a pattern resembling Ngn3 (compare A to D). 
At HH st. 31, Ngn3 is expressed in scattered cells within the 
epithelium (E) where they co-localize with Nkx6.1 (I). Ngn3 
is not expressed in glucagon positive cells adjacent to the 
Nkx6.1 positive epithelium (I). In contrast, NeuroD express-
ing cells are confined to endocrine cells and are excluded 
from the Nkx6.1 positive epithelium (F, J, area corresponding 
to boxed areas in E, H). Hairy-1 is still expressed broadly in 
the epithelium (G) and some of the forming amylase positive 
acini are also positive for Hes1 (black arrowhead in G, K) but 
amylase positive acini without Hes1 expression can also be 
found (red arrowhead in G, K). Hes6-1 is expressed in a pat-
tern closely resembling Ngn3 (H) as it co-localizes with 
Nkx6.1 in the epithelium and is excluded from glucagon posi-
tive endocrine cells (L). * denotes Nkx6.1 positive β-cellsBMC Developmental Biology 2007, 7:63 http://www.biomedcentral.com/1471-213X/7/63
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Similar experiments using a truncated Delta1 construct
(Delta1-d1, [28]) were inconclusive as very few GFP+ cells
remained 48 hours after electroporation and none were
detectable after 72 hours. Quantitatively, mis-expression
of Delta1 beginning at HH st. 10–12 or HH st. 13–15
resulted in an increase of the fraction of endocrine GFP+
cells from ~40% to ~75% and from ~20% to ~50%,
respectively (Fig. 2E). In extreme cases pancreas morphol-
ogy was severely altered with the dorsal pancreas adopting
a tubular morphology with the epithelium composed
almost exclusively of endocrine cells (Fig. 3 compare B to
A). Notably, forced expression of Delta1 had no endocri-
nogenic effect in the prospective duodenum (Fig. 3B). If
the effect of the ligands were a cell-autonomous inhibi-
tion of Notch signaling then this effect should be blocked
by a constitutive activation of the Notch pathway in the
same cell. To test this, we co-expressed Delta1 with a con-
stitutively active form of Notch1 (Notch1ICD)[17] in the
chick pancreas by in ovo electroporation. In agreement
with this model we found that Notch1ICD was able to
reverse the effect of Delta on endocrine differentiation
such that most transfected cells were excluded from the
endocrine area under these conditions (Fig. 3B,C).
To test if ectopic expression of the ligands also induced
exocrine differentiation we compared the expression of
the exo- and endocrine markers amylase and glucagon,
respectively, in control and Delta1 electroporated chicken
pancreata (Fig 3D,E). GFP-expressing cells were evenly
distributed throughout the pancreas epithelium, includ-
ing exocrine and endocrine cells in the control pancreas.
In contrast, the majority of the GFP positive cells
expressed glucagon and were excluded from the exocrine
cells in Delta electroporated pancreata. Furthermore, the
Delta1-expressing pancreata were consistently smaller,
suggesting that Delta1 induces precocious endocrine dif-
ferentiation at the expense of progenitor expansion and
later born cell types such as the exocrine.
Constitutively active Notch1 prevents endocrine 
differentiation and maintains proliferation
The results above suggest that Notch signaling inhibits
endocrine differentiation in the chicken pancreas and that
this inhibitory signal must be terminated before differen-
tiation can occur. To test the effect of a constitutive activa-
tion of Notch signaling on normal pancreas development
we introduced Notch1ICD [17] by in ovo endoderm electro-
poration at HH st. 13–15 and analyzed endocrine devel-
opment after 52 hours (HH st. 21–23)(Fig. 4). We found
that GFP+ cells in embryos expressing the control vector
readily contributed to α- and β-cells as determined by co-
localization of GFP with glucagon and insulin (Fig. 4A),
while GFP+ cells in Notch1ICD-expressing embryos were
only rarely found to co-express glucagon or insulin (Fig.
4D). Quantitative analysis revealed that only ~1% of the
GFP+  cells in the Notch1ICD-expressing pancreas were
endocrine compared to 8% for control embryos (Fig. 4G),
demonstrating that Notch1ICD blocks endocrine differen-
tiation also in the chicken pancreas. The few cells we did
find co-expressing Notch1ICD and endocrine markers can
be explained by the occasional electroporation of existing
endocrine cells at the time of electroporation [11].
In addition to reduced endocrine development we also
observed that the morphology of the pancreas anlage in
Notch1ICD-expressing embryos was disturbed compared
to control embryos, such that the Nkx6.1+ pancreas epi-
thelium appeared expanded and highly folded compared
to controls (Fig. 4, compare B and E). We hypothesized
that the folded epithelium we observed in Notch1ICD
expressing pancreas could be the result of increased prolif-
eration. We therefore analyzed proliferation of the
Nkx6.1+ pancreas epithelium using a monoclonal anti-
body against MPM2 which is a marker for mitotic cells
[34]. We found that the fraction of Notch1ICD-expressing
cells in the pancreas epithelium that expressed MPM2 was
2.5-fold higher than for corresponding cells expressing
the control plasmid (Fig. 4C,F and Fig. 5I), demonstrating
that active Notch signaling inhibits differentiation which
is coincident with ongoing proliferation of pancreatic epi-
thelial cells. These data lend further support to the notion
of Notch signaling acting primarily to maintain a progen-
Inhibition of Notch signaling induce excess endocrinediffer- entiation Figure 2
Inhibition of Notch signaling induce excess endocrin-
edifferentiation. (A-D). Confocal sections of chicken 
embryonic pancreata 72 hours after electroporation with 
control vector (A), Delta1 (B), Serrate1 (C), and Serrate1-d1 
(D) subjected to immunohistochemical stainings against GFP 
(green) and glucagon plus insulin (red). Cells expressing GFP 
from the vector readily co-localize with endocrine markers. 
However, most electroporated cells are not endocrine (A). 
In contrast, electroporation with either Delta1, Serrate1, or 
Serrate-d1 results in increased endocrine differentiation of 
electroporated cells as compared to the control (compare B, 
C, D to A). E. Quantitative analysis of endocrine differentia-
tion 72 hours after electroporation with the indicated 
expression plasmids at HH st. 10–12 or HH st. 13–15. (F, G).BMC Developmental Biology 2007, 7:63 http://www.biomedcentral.com/1471-213X/7/63
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itor state, rather than inducing an alternative differenti-
ated cell fate [35].
Ngn3 induced cell cycle withdrawal and differentiation is 
antagonized by Notch1ICD
The results described above suggest that Notch mediated
control of endocrine pancreas development is conserved
in chicken. Previous results obtained in mice have indi-
cated that Notch signaling acts to repress Ngn3 expression
and thereby prevents endocrine differentiation
[10,17,18]. However, it is also possible that Notch signal-
ing may additionally act in cells that already have initiated
Ngn3  expression by antagonizing the function of the
encoded protein Ngn3 [16]. To test if activated Notch
could interfere with the ability of Ngn3 to induce endo-
crine differentiation we took advantage of the ability of
ectopic Ngn3 to induce endocrine differentiation in the
chick endoderm [11]. We confirmed that Ngn3 induced
endocrine differentiation in the chick pancreas (Fig. 5).
Most Ngn3 positive cells were Nkx6.1 negative and Pax6
positive, suggesting they had differentiated into α-cells
(Fig. 5A,B). In agreement with this we found that many
Ngn3 positive cells expressed glucagon while insulin-
expressing cells were rare (Fig. 5C). Mitotic cells were
extremely rare among the Ngn3-expressing cells as judged
by MPM2 immunoreactivity (Fig. 5D,I) similar to the sit-
uation in mouse where early endocrine cells are post
mitotic [22]. To test if active Notch signaling can prevent
Ngn3-induced endocrine differentiation in the chick pan-
creas, we co-electroporated HH st. 13–15 embryos with
Ngn3 and Notch1ICD  expression vectors and assayed
endocrine development after 52 hours. In contrast to
embryos electroporated with the Ngn3 vector alone we
found that most co-electroporated cells maintained
Nkx6.1 expression (Fig. 5E) and displayed a high percent-
age of MPM2 expression (Fig. 5H,I) whereas very few cells
expressed Pax6, glucagon or insulin (Fig. 5F,G). This
result demonstrates that activated Notch1 can inhibit the
function of the Ngn3 protein.
Hes5-1 and Hes6-1 is inversely regulated by Ngn3 and 
Notch1ICD
To begin to unravel the mechanism behind Notch-medi-
ated inhibition of endocrine development, we next inves-
tigated the expression pattern of Hes1, Hes5-1, Hes6-1, and
NeuroD  in the pancreas after introduction of Ngn3,
Notch1ICD and Ngn3 + Notch1ICD or control vector (Fig.
6). The expression pattern of these genes was not affected
in embryos electroporated with control vector (compare
Notch1ICD directly regulates proliferation and blocks endo- crine differentiation Figure 4
Notch1ICD directly regulates proliferation and blocks 
endocrine differentiation. (A-F). Confocal sections of 
chicken embryonic pancreata 52 hours after electroporation 
with empty vector (A-C) or Notch1ICD (D-F) subjected to 
immunohistochemical stainings against glucagon (red), and 
insulin (blue) (A and D), Nkx6.1 (red) (B and E), and MPM2 
(red) (C and F). GFP was detected by its endogenous fluores-
cence (A-F). Inserts in A-F show higher magnifications of the 
boxed areas in the cognate panels. (G) Bar graph illustrating 
the quantitative analysis of endocrine differentiation 52 hours 
after electroporation with control vector or Notch1ICD plas-
mid at HH st. 13–15. Note the absence of insulin and gluca-
gon and the presense of MPM2 in GFP-positive cells in the 
Notch1ICD electroporated embryos.
Cell autonomous effects of ligand expression is reversed by  Notch1ICD Figure 3
Cell autonomous effects of ligand expression is 
reversed by Notch1ICD. 3D projections of confocal optical 
sections of chicken embryos subjected to whole mount 
immunohistochemical stainings for GFP (green) and glucagon 
plus insulin (red) (A-C) or GFP (green), glucagon (red) and 
amylase (blue) (D, E) 72 hours after electroporation with the 
indicated constructs. The most extreme phenotype resulting 
from ectopic Delta1 expression is an almost complete con-
version of the pancreas into a tubular structure composed 
almost entirely of endocrine cells (compare B to A). When 
Delta1 is co-expressed with Notch1ICD most transfected 
cells do not express the hormones (C). D and E show the 
entire dorsal pancreas at the same magnification (scale bar 
represents 100 µm). Note the even distribution of electro-
porated cells in the control (D) and the clustering of electro-
porated cells in the endocrine population in the Delta1 
electroporated pancreas.BMC Developmental Biology 2007, 7:63 http://www.biomedcentral.com/1471-213X/7/63
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Fig. 6B,D,E to Fig. 1B,C,D and not shown for Hes5-1).
Conversely, Ngn3 electroporation led to loss of Hes1
expression and a robust induction of NeuroD and Hes6-1
in the electroporated area (Fig. 6G,I,J). In contrast,
Notch1ICD repressed NeuroD and Hes6-1 expression in the
electroporated area (Fig. 6N,O). Notably, we found no
evidence to suggest that Notch1ICD up-regulated Hes1 (Fig.
6L) and it even appeared to be down-regulated in the
transfected area. Instead, Hes5-1, another Notch target
gene [27,36] not normally expressed in the pancreas epi-
thelium, was strongly induced in Notch1ICD expressing
cells (Fig. 6M). In the developing nervous system of the
mouse, Hes1 and Hes5 are expressed in complementary
patterns and Hes5 expression is expanded in the Hes1 null
mice and vice versa indicating mutual cross repression
[37]. Hes5 expression is also induced in the endoderm of
Hes1 null mice [13]. In the chick embryo Hes5-1 is known
to repress the expression of other chicken Hes genes [27]
and it is possible that it also respresses Hes1 under these
conditions. Similar results were recently reported by Mat-
suda et al. who found that ectopic expression of
Notch1ICD in chick embryonic stomach endoderm failed
to up-regulate transcription of Hes1 and Hairy2, two Hes
homologues normally found to be expressed in this tissue
[38]. When Ngn3 and Notch1ICD were co-electroporated
we observed a robust induction of Hes5-1  expression
while Ngn3-induced NeuroD and Hes6-1 expression was
lost (Fig. 6Q–T). Hes1  also appeared down-regulated
under these conditions.
Activated Notch1 inhibits Ngn3 and NeuroD induced 
endocrine differentiation but not delamination
Our finding that Notch1ICD inhibits both expression and
function of Ngn3 is consistent with previous reports
showing that X-NotchICD inhibits both the expression and
function of the Ngn3 related X-NGNR-1 during Xenopus
neurogenesis [39,40]. Furthermore, since X-NGNR-1 can
induce XNeuroD expression while the converse is not the
case [39] it appears that a unidirectional bHLH cascade
regulates neural determination and differentiation (regu-
lated by Neurogenin and NeuroD, respectively). Whether
either or both of these processes are repressed by Notch
signaling is not fully understood. Furthermore, it is still
bHLH genes are inversely regulated by Ngn3 and Notch1ICD Figure 6
bHLH genes are inversely regulated by Ngn3 and 
Notch1ICD. (A-T). In situ hybridization on serial sections 
from embryonic pancreata 52 hours after electroporation 
with control vector (A-E), Ngn3 (F-J), Notch1ICD (K-O), or 
Ngn3 and Notch1ICD (P-T). The expression patterns of Hes1 
(B, G, L, Q)), Hes5-1 (C, H, M, R), Hes6-1 (D, I, N, S), and 
NeuroD (E, J, O, T) were examined. A, F, K, P show GFP 
expressing electroporated cells (arrowheads) and the corre-
sponding area is indicated with arrowheads in the rest of the 
panels. Note that Notch1ICD apparently leads to decreased 
Hes1 expression (red arrowhead in L and arrowheads in Q) 
and induces Hes5-1 expression (M, R) and repress Hes6-1 (N, 
S) and NeuroD (O, T) expression regardless of the presence 
of Ngn3.
Notch1ICD inhibits the activity of Ngn3 Figure 5
Notch1ICD inhibits the activity of Ngn3. (A-H). Confocal 
sections of chicken embryonic pancreata 52 hours after elec-
troporation with Ngn3 (A-D) or Ngn3 and Notch1ICD (E-H) 
subjected to immunohistochemical stainings against Nkx6.1 
(red) (A, E), Pax6 (red) (B, F), glucagon (red) and insulin 
(blue) (C, G), or MPM2 (red) (D, H). GFP was detected by its 
endogenous fluorescence (A-H). Inserts show higher magnifi-
cation of boxed areas in the cognate panels. (I) Bar graph 
illustrating the quantitative analysis of MPM2/GFP double-
positive cells as a percentage of total GFP-positive cells 52 
hours after electroporation with the indicated expression 
plasmids at HH st. 13–15. Note the absence of insulin and 
glucagon, the presense of MPM2, and persistent Nkx6.1 
expression in GFP-positive cells in the Ngn3 plus Notch1ICD 
electroporated, compared to Ngn3 electroporated embryos.BMC Developmental Biology 2007, 7:63 http://www.biomedcentral.com/1471-213X/7/63
Page 7 of 13
(page number not for citation purposes)
unknown whether NeuroD can induce Ngn3 expression,
and the sensitivity of these bHLH factors to Notch medi-
ated inhibition in endocrine development has not previ-
ously been investigated. To test if the Neurogenin-NeuroD
cascade is unidirectional in endocrine development we
compared the effect of introducing Ngn3 and NeuroD. We
analyzed Ngn3 expression by in situ hybridization in Neu-
roD electroporated cells but found no evidence to suggest
that NeuroD induce Ngn3 expression (not shown), con-
sistent with similar studies in the nervous system [39] and
indicating that NeuroD activates the differentiation pro-
gram independent of Ngn3. However, we cannot exclude
a transient induction of Ngn3 at earlier timepoints not
analyzed. Next we examined if Notch1ICD could block the
differentiation induced by Ngn3 or NeuroD by perform-
ing co-electroporation experiments (Fig. 7). In these
experiments we targeted the prospective duodenum
where no endocrine development occurs at the stages
examined unless Ngn3 is induced and where delamina-
tion of differentiating endocrine cells is more readily
scored [11]. We used an antibody to laminin to visualize
the basal lamina of the endodermal epithelium and Pax6,
glucagon, somatostatin and neuronal classIII β-tubulin
[41] specific antibodies as endocrine markers. In our
experiments both Ngn3 and NeuroD induced endocrine
differentiation as evidenced by Pax6-, glucagon-, somato-
statin-, and neuronal classIII β-tubulin expression and
delamination of the differentiated cells (Fig. 7A,B and
7E,F). However, when Notch1ICD was co-expressed with
either Ngn3 or NeuroD we found an almost complete loss
of all these endocrine markers (Fig. 7C,D and 7G,H),
showing that during forced endocrine differentiation both
Ngn3 and NeuroD function is sensitive to Notch. Delam-
ination of Ngn3 and NeuroD expressing cells still
occurred under these conditions (Fig. 7, compare A to C
and E to G), showing that delamination and expression of
differentiation markers can be uncoupled during endo-
crine development.
Myt1 can partially antagonize the effects of Notch1ICD on 
Ngn3 function
The above experiments demonstrate that activated
Notch1 can inhibit both Ngn3- and NeuroD-induced
endocrine development. Since certain Ngn3-induced gene
products, such as Hes6-1 and MyT1, have been reported to
attenuate Notch mediated inhibition [42,43] we wanted
to analyze if expression of any of these genes was insensi-
tive to Notch inhibition in the duodenum, thus possibly
explaining the delamination observed in the presence of
activated Notch. As mentioned above (Fig. 6 and 7), both
native and Ngn3-induced NeuroD and Hes6-1 expression
in the pancreas is sensitive to Notch inhibition but dela-
mination is not readily scored in the pancreas due to the
branching of the epithelium. We therefore repeated the
experiment in the duodenum and found that Ngn3-
Differentiation can be uncoupled from delamination Figure 7
Differentiation can be uncoupled from delamination. 
(A-H). Confocal sections of chicken embryonic pancreata 52 
hours after electroporation with Ngn3 (A-B), Ngn3 and 
Notch1ICD (C-D), NeuroD (E-F), or NeuroD and Notch1ICD 
(G-H) subjected to immunohistochemical stainings against 
Pax6 (red) and laminin (blue) (A, C, E, G) and glucagon (red) 
and somatostatin (blue) (B, D, F, H). GFP was detected by its 
endogenous fluorescence (A-H). Inserts show higher magnifi-
cation of boxed areas in the cognate panels. Note that 
Notch1ICD inhibits Ngn3 and NeuroD induced expression of 
endocrine markers without affecting delamination of the cells 
from the endoderm.BMC Developmental Biology 2007, 7:63 http://www.biomedcentral.com/1471-213X/7/63
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induced expression of these two genes as well as MyT1 was
repressed by Notch1ICD also at that location (Fig. 8A–H).
This result suggests that Ngn3 can initiate a delamination
program independent of the activity of these genes and
that Ngn3 may have actions insensitive to Notch repres-
sion.
The levels of Notch1ICD resulting from forced expression
are likely much higher than found during native Notch
signaling events. Our experiments therefore do not rule
out that Hes6-1 and/or MyT1 could render cells refractive
to the action of more physiological levels of Notch as seen
in neurogenesis [43]. To test if forced expression of MyT1
at high levels could antagonize Notch1ICD function we
electroporated chicken endoderm with constructs encod-
ing Ngn3, Notch1ICD and a FLAG tagged Nzf2b isoform of
Myt1. This is one of two Myt1 isoforms resulting from
alternative transcriptional start sites reported to be
expressed at highest levels in the mouse pancreas. Further-
more, it is the only isoform capable of initiating the endo-
crine differentiation program in the chicken endoderm
[44]. We found that expression of MyT1 led to a partial
restoration of neuronal classIII β-tubulin expression (Fig.
8I–K), indicating that some aspects of endocrine differen-
tiation have been rescued in these cells. Expression of
Pax6, glucagon and somatostatin was, however, not
restored under these conditions (not shown), suggesting
that other factors are needed to overcome the repression
by Notch1ICD.
Discussion
The pancreatic expression of bHLH genes and their sensi-
tivity to Notch mediated inhibition observed in this study
suggests that endocrine development is highly conserved
between mice and chicken.
Overexpression of Notch ligands leads to endocrine 
differentiation
The observed stimulatory effect of Delta1 over-expression
upon endocrine differentiation is in contrast to the effect
of Delta1 over-expression in the chicken retina where
widespread RCAS-mediated expression of Delta1 inhibits
neuronal differentiation [45], and seemingly at odds with
the proposed function of Delta1 as a signal that inhibits
endocrine differentiation. However, high level expression
of Notch ligands has previously been reported by a
number of groups to result in cell autonomous inhibition
of Notch signal reception [28-33], raising the possibility
that the effect we observe is cell autonomous and the
result of inhibition of Notch signaling rather than stimu-
lation of Notch signaling in neighboring cells. In our
experiments we used plasmid-based electroporation
which results in multiple copies being taken up by the
electroporated cells which combined with the very strong
promoter used may result in expression levels exceeding
those obtained by Henrique and colleagues who used an
RCAS retrovirus-mediated delivery [45]. Furthermore,
expression of a truncated signaling-defective version of
Serrate-1 also resulted in enhanced endocrine develop-
ment, arguing that the effects we observe with full-length
Delta1 and Serrate-1 is the result of a dominant negative
effect. This was further corroborated by the ability of
Notch1ICD to reverse the effect of the ligands in a cell
autonomous manner. However, in spite of the cell-auton-
omous effect on Notch signal reception, we would expect
that cells lying adjacent to cells expressing Delta1 or
Serrate1 would be prevented from differentiating through
the non-cell autonomous activation of Notch signaling in
neighboring cells, while this effect should not be observed
for cells lying next to Serrate-d1-expressing cells which are
signaling defective. However, since differentiating endo-
crine cells delaminate from the epithelium we were not
able to ascertain whether differentiation of cells initially
lying adjacent to Delta1- or Serrate1-expressing cells was
delayed or inhibited.
It is noteworthy that we always observe that a fraction of
the ligand expressing cells fail to undergo endocrine dif-
Myt1 can partially rescue the inhibitory effect by Notch1ICD  on Ngn3 function Figure 8
Myt1 can partially rescue the inhibitory effect by 
Notch1ICD on Ngn3 function. (A-K). Immunohistochemi-
cal stainings (A, E, I-K) and in situ hybridizations (B-D, F-H) 
on sections in the duodenum 52 hours after electroporation 
with Ngn3 (A-D, I), Ngn3 and Notch1ICD (E-H, J) or Ngn3 
with Notch1ICD and MyT1 (K) showing expression of Ngn3 
(A, E), NeuroD (B, F), Myt1 (C, G), Hes6-1 (D, H), and βIII-
tubulin. Note that Ngn3 fails to induce expression of endo-
crine markers in the presence of Notch1ICD. βIII-tubulin 
expression is partially restored when Notch1ICD and MyT1 
are co-expressed with Ngn3 (compare K to J and I).BMC Developmental Biology 2007, 7:63 http://www.biomedcentral.com/1471-213X/7/63
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ferentiation and that this fraction increases with time.
One possible explanation for this is that these cells are dif-
ferentiating into acinar cells as premature acinar differen-
tiation is observed in zebrafish with compromised Notch
signaling [19]; however, we found no evidence to suggest
that amylase expression occurred prematurely. It is also
possible that such cells are committed to a non-endocrine
fate and that inhibition of Notch signaling therefore can-
not induce endocrine differentiation. In this regard it is
notable that forced expression of Ngn3 also fails to induce
endocrine differentiation of all the cells that express the
introduced gene. However, a trivial explanation may be
that the cells that fail to differentiate express the intro-
duced genes at levels that are incompatible with endo-
crine differentiation.
The endocrinogenic effect of Notch ligand expression was
confined to the pancreatic endoderm. In spite of wide-
spread expression in prospective duodenum we found no
signs of endocrine development. This is most likely due to
the restriction of Ngn3 expression to the pancreas anlage
at this stage, but apparently contrasts with recent data
from Gu and colleagues who found that forced expression
of Manic Fringe in prospective duodenum led to endo-
crine development through inhibition of Notch signaling
[46]. The reason for this discrepancy is unclear at present
but could be related to the different mechanisms by which
Manic Fringe and high levels of Delta1 inhibits Notch sig-
nal reception.
Activated Notch inhibits endocrine promoting Ngn3 
activity
Previous studies of Notch function in pancreatic endo-
crine development have not considered a potential role
for Notch mediated inhibition of Ngn3 and/or NeuroD
protein function. Several examples of post-translational
inhibition of pro-neural function by Notch have been
described in the literature. The function of the exocrine
bHLH factor p48-PTF1 has been shown to be inhibited via
heterodimerization to Hes1 [19]. In Drosophila, several
Notch target genes of the E(Spl) class have been shown to
dimerize with pro-neural bHLH factors and antagonize
the function of these [14], in Xenopus X-NGN1 function
can be antagonized by activated Notch1 [39,40], and in
human cell lines Notch signaling has been demonstrated
to lead to a rapid degradation of the human achaete-scute
homolog hASH1 [15]. It is possible that similar mecha-
nisms regulate Ngn3 function. It is also possible that reg-
ulatory sequences of genes induced by Ngn3 also contain
Hes binding sites and that Hes repressor activity is domi-
nant over Ngn3. Although our results do not prove that
Notch signaling is active in Ngn3-expressing precursors
they do raise the possibility that Notch might have a sec-
ond effect in endocrine differentiation in that it could reg-
ulate the levels and duration of Ngn3 activity. A similar
but not identical experiment has been conducted by Mur-
taugh and colleagues who used Ngn3-Cre mice to condi-
tionally mix-express Notch1ICD in endocrine progenitor
cells which led to inhibition of endocrine differentiation
[18]. However, since Ngn3 expression was not investi-
gated in that study it is unclear whether this block in
endocrine development was caused by inhibition of Ngn3
gene expression or Ngn3 protein activity. Recently,
Notch1ICD was shown to re-direct endocrine progenitors
to a duct cell fate when expression was induced in Pax4-
expressing cells [47]. Presumably, this effect would
require inhibition of Ngn3 as Pax4 is a target of Ngn3.
A surprising finding is that activated Notch did not result
in significant upregulation of Hes1 in the pancreas but
rather appeared to repress the expression of this Notch
effector gene. As discussed above this may be a secondary
effect to the induction of Hes5-1. In a transgenic mouse
expressing Notch1ICD under the Pdx1 promoter, Hes1 pro-
tein could not be detected in most of the Notch1ICD
expressing pancreatic cells even though Ngn3 expression
was almost completely abolished throughout the epithe-
lium[17]. It was speculated that the Hes1 protein is
expressed at levels too low for detection by immunohisto-
chemistry. An alternative interpretation is that the effect of
Notch1ICD is mediated by other Hes factors such as Hes5,
or that Notch signaling may be required but not sufficient
for Hes1 expression under normal circumstances.
Surprisingly, Ngn3-induced delamination still occurred in
the presence of Notch1ICD. The molecular mechanism
controlling delamination of endocrine cells is poorly
defined but it is possible that Ngn3-targets responsible for
delamination are less sensitive to Notch-mediated repres-
sion than targets genes involved in endocrine differentia-
tion, e.g., if genes required for delamination lack Hes
binding sites in their regulatory elements. Intriguingly,
differentiation and delamination is also uncoupled in
other circumstances. A mutant Ngn3 protein carrying a
missense mutation (R107S) is hypomorphic in regard to
endocrine-inducing activity, but still capable of inducing
delamination to the same extent as wild-type Ngn3 [48].
Activated Notch antagonize Ngn3 as well as NeuroD 
function
Conditional expression of Notch1ICD in mature insulin-
producing beta cells has no apparent effect on the beta cell
phenotype [18]. Since NeuroD function is required for
beta cell survival and function [49,50] we speculated that
NeuroD might be refractive to the effects of activated
Notch. However, endocrine differentiation induced by
forced NeuroD expression in chicken endoderm was com-
pletely prevented by co-expression of Notch1ICD. This
could reflect a mechanistic change in NeuroD function in
mature endocrine cells compared to precursor cells. InBMC Developmental Biology 2007, 7:63 http://www.biomedcentral.com/1471-213X/7/63
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agreement with this notion we found that a few endocrine
cells in the pancreas expressed Notch1ICD probably reflect-
ing the occasional transfection of existing endocrine cells
at the time of electroporation. Alternatively, it is possible
that the ROSA26 locus, used to conditionally express
Notch1ICD by Murtaugh and colleagues, results in appreci-
ably lower levels of expression than we obtain by electro-
poration and that high level expression of Notch1ICD is
required for repression of NeuroD function. NeuroD is
also capable of inducing neurogenesis when expressed in
Xenopus  ectoderm [39,51] but it is unclear if activated
Notch can inhibit this function of NeuroD. In one study,
X-NGNR-1 and XNeuroD were equally sensitive to inhibi-
tion by X-NotchICD  in side-by-side comparisons [39],
while in another study the number of neurons formed in
response to X-NGNR-1 was reduced by X-NotchICDwhich
was not the case for XNeuroD induced neurons [40]. A
number of observations support a similar function in pan-
creatic endocrine development; forced expression of
either Ngn3 or NeuroD in the pancreas can induce the
endocrine differentiation program [8,10,11] and Ngn3
induces NeuroD expression [10,11], while NeuroD cannot
induce Ngn3 expression (this study) suggesting that a uni-
directional bHLH cascade may also regulate endocrine
determination and differentiation.
MyT1 antagonism of Notch1ICD activity
During Xenopus neurogenesis MyT1 can in cooperation
with X-NGNR-1 overcome the repressive activity of Notch
upon X-NGNR-1 [43]. We observe only a partial antago-
nistic effect of MyT1 on Notch mediated repression of
Ngn3 function. The reasons for this incomplete rescue is
unclear but it is possible that the chicken electroporation
system results in far higher levels of activated Notch than
seen with mRNA injection in Xenopus oocytes. It is possi-
ble that MyT1 would have a greater effect if more physio-
logical expression levels were used. Nevertheless, the
expression of known Notch signaling modifiers such as
Hes6-1, Myt1, and Manic Fringe in endocrine precursors
[44,46] suggests that Notch signaling is finely regulated
during the early stages of endocrine differentiation. How-
ever, conditional loss-of-function studies in mice are
needed to further elucidate the cellular and biochemical
mechanisms of Notch signaling during these early stages
of endocrine development.
Conclusion
Together the data presented here establish that pancreatic
endocrine development in the chicken relies in a con-
served bHLH cascade under inhibitory control of Notch
signaling. While this may not be surprising it does lay the
ground for further studies that take advantage of the ease
at which chicken embryos can be manipulated.
Our results also raise the possibility that Notch could act
in Ngn3-expressing cells and delay their differentiation.
To determine whether Notch in fact does act upon Ngn3
in vivo will require sophisticated conditional mutagene-
sis.
Lastly, our results demonstrate that expression of differen-
tiation markers can be uncoupled from the process of
delamination of differentiating cells from the epithelium.
Methods
DNA constructs
All expression constructs were made in a pCIG vector [52]
optimized for EGFP intensity (pCIG5 or pCGIG5 with a
Gateway (invitrogen) recombination cassette, kindly pro-
vided by Anne Grapin-Botton). A pcDNAI vector contain-
ing a cDNA encoding N-terminal haemaglutinin (HA)
tagged mouse Ngn3 was kindly provided by François Guil-
lemot. This vector was cut with HindIII and filled with kle-
now. The cDNA was released with NotI and the entire
fragment was cloned into the EcoRV/NotI sites of pCIG5.
The cDNA encoding N-terminally HA tagged rat NeuroD
has been described previously [53]. The coding sequence
was amplified by PCR with the primers CACCAT-
GGGCTACCCATAGAT and CTAATCGTGAAAGAT-
GGCATT and TOPO cloned into the pENTR/D vector
(Invitrogen). Subsequently, HA-NeuroD  was cloned by
recombination into pCGIG5. The cDNA encoding C-ter-
minally myc tagged rat Notch1ICD has been described pre-
viously [17]. An EcoRI fragment containing the entire
coding sequence was cloned into the EcoRI site of pCIG5.
The mouse Myt1-7zf gene was FLAG tagged (MDYKD-
DDDKMTKSYSESGL) at the N terminus using PCR and
cloned into pENTR/D (invitrogen). The tagged version of
Myt1-7zf was cloned into the pCGIG5 vector using gate-
way cloning. The cDNAs encoding FLAG tagged chicken
Delta1 and HA tagged chicken Serrate1 and the dominant
negative Serrate1-d1 were a kind gift from Ken-ichi Kat-
sube [28]. Delta1-FLAG was released with ApaI (Klenow
blunted) and BamHI and ligated to EcoRI (Klenow
blunted) and BamHI sites in pEntr 2B (Invitrogen). The
coding sequence was cloned into the pCGIG vector by
Gateway recombination. The Serrate constructs were
cloned into XhoI and EcoRI sites of pEntr 2B and subse-
quently inserted in the pCGIG vector by Gateway cloning.
All constructs were verified by sequencing.
In ovo endoderm electroporation
Electroporations were performed as described in [11].
Briefly, fertilized White Leghorn eggs (Triova, Denmark)
were incubated at 38°C, 50% relative humidity. Electro-
poration was performed on chicken embryos at HH st.
10–15 [23] : The eggs were windowed and a solution of
DNA (with a fixed concentration of 2 µg/µl in PBS w/o
Ca2+ and Mg2+, 1 mM MgCl2, 3 mg/ml carboxymethyl-BMC Developmental Biology 2007, 7:63 http://www.biomedcentral.com/1471-213X/7/63
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cellulose, 0.66 mg/ml Fast Green) was injected into the
blastocoel. An anode was placed over and a cathode under
the embryo along the anteroposterior axis of the embryo
using a micromanipulator. Depending on stage, three to
five square 50 ms pulses of 7–15 V were applied from a
BTX ECM830 electroporator and the eggs were sealed and
returned to the incubator and allowed to develop for 52–
72 hours. Electroporated embryos were immunostained
with an antibody specific for the epitope tags and co-local-
ization with GFP was assayed: As expected we found that
most GFP positive cells also expressed the epitope tags
(not shown) and we therefore used GFP as a measure of
productive expression. For co-expression experiments
double immunohistochemistry against the different
epitope tags was used to verify co-expression (not shown).
Immunohistochemistry and statistical analyses
Whole mount immunofluorescent stainings: The stomach
with the proximal duodenum along with the pancreas was
dissected from the embryos and fixed over night in 4%
PFA at 4°C. Specimens were processed as in [54]. For IHC
on sections, embryos were fixed in 4% PFA at 4°C over
night, equilibrated in 30% sucrose in PBS and frozen in
Tissue-Tek OCT compound (Sakura finetek). 10 µm sec-
tions were obtained on a Leica CM3050 S cryostat and col-
lected on SuperFrost plus (Menzel-Gläser) slides. Sections
were washed in PBS and blocked for at least 1 hour in
0.5% TNB (PerkinElmer). Primary antibodies were
diluted in 0.5% TNB and applied over night. Secondary
antibodies were applied for 1 hour after several washes in
PBS and slides were mounted in 20% glycerol (in 50 mM
Tris buffer adjusted to pH8.4). Primary antibodies were:
Mouse-anti-HA (HA.11, Babco), rabbbit-anti-myc (A14,
Santa Cruz), mouse-anti-FLAG (M2, Sigma), Mouse-anti-
glucagon (Glu-001, Novo Nordisk A/S), guinea pig-anti-
insulin (ab7842, Abcam), rabbit-anti-somatostatin
(A566, DAKO), rabbit-anti-amylase (A 8273, Sigma), rab-
bit-anti-Laminin (L9393, Sigma), mouse-anti-MPM2
(M3514, DAKO), rabbit-anti-βIII-Tubulin (PRB-435P,
Nordic Biosite). rabbit-anti-Nkx6.1 [55], rabbit-anti-GFP
(632460, Clontech), (DSHB) The mouse anti-Pax6 mon-
oclonal antibody developed by Atsushi Kawakami was
obtained from the Developmental Studies Hybridoma
Bank developed under the auspices of the NICHD and
maintained by The University of Iowa, Department of
Biological Sciences, Iowa City, IA 52242. Secondary anti-
bodies were purchased from Jackson ImmunoResearch
(Cy3 conjugated donkey-anti-rabbit and donkey-anti-
guinea pig and Cy5 conjugated donkey-anti-mouse). Neg-
ative controls include omission of primary antibodies and
staining of non-electroporated embryos Images were col-
lected by confocal microscopy on an LSM 510 META Laser
Scanning Microscope (Carl Zeiss) and fluorescent signals
were assigned false colors with Zeiss LSM software. Quan-
tification was performed by sampling sections covering all
the electroporated endoderm (between 7 and 10 sections
from each embryo) and counting at least between 350 and
750 GFP+ cells from embryos electroporated at HH st. 10–
12 and between 1200 and 4800 for embryos electropo-
rated at HH st. 13–15. Between 3 and 13 embryos were
analyzed quantitatively for each condition. Statistical
analyses were performed using Student's T-test.
In situ hybridization
Digoxigenin labelled cRNA probes were generated by in
vitro transcription using reagents from Roche according to
manufacturer's instruction. The following chicken cDNA
clones were used for probe generation: Ngn3 was kindly
provided by A. Grapin-Botton and J. M. Matter. Delta1,
Notch1, Serrate1 and Serrate2 were generous gifts from D.
Henrique [56,57]. NeuroD: ChEST695k11, Hes1:
ChEST900h16,  Hes6-1: ChEST296l7, Hes6-2:
ChEST529e6,  Hes5-1: ChEST295o19, Myt1:
ChEST672b12, Notch2: ChEST909l22. ChEST clones were
from the BBSRC Chick EST database and purchased from
MRC gene service. Wholemount ISH was performed
essentially as in [26]. ISH on frozen sections: Frozen sec-
tions were thawed and denatured cRNA probes diluted to
1 ng/µl in hybridization solution (50% formamide, 1x
salt, 10% Dextran sulphate, 1 mg/ml yeast tRNA, 1x Den-
hardts) were added directly to the sections. The sections
were covered with a cover slip and placed in a humidified
chamber (humidified with 5×SCC, 50% formamide) at
65°C over night. The slides were washed 3 times in wash
solution (50% formamide, 1× SCC, 0.1% Tween-20) at
65°C followed by several washes in MABT (100 mM
maleic acid, 150 mM NaCl, 0.1% Tween-20, adjusted to
pH7.5 with NaOH) at room temperature. The sections
were blocked in 2% blocking reagent (Roche), 20% heat
inactivated goat serum in MABT for 1 hour and incubated
over night with an AP conjugated sheep-anti-DIG (Roche)
(1:2500 in blocking solution). The sections were washed
in MABT and then equilibrated in NTMT (50 mM Tris, 0.1
M NaCl, 0.02 M MgCl2, 0.1% Tween-20, pH9.5). AP activ-
ity was visualized with NBT/BCIP in NTMT. Images were
collected with a Hamamatsu C5810 cooled CCD camera
mounted on an Olympus BX51 microscope and processed
in Adobe Photoshop™.
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